Pfizer's and Moderna's formulas have been the go-to on pharmacy shelves, but Novavax remains an important option.

October: time for muddy soccer practices, cider pressing and Halloweentown ... And time to roll up your sleeves.

It’s that time of year again: the dreaded cold and flu season is on the horizon. But lurking in the shadows is a more sinister threat: RSV.

The truth is 80% of babies under 1 year old catch RSV. “They probably mostly catch it from other children,” said Andrew Pavia, MD, Pediatric Infectious Disease at University of Utah Health/Primary ...

Topline results were announced from a phase 3 study assessing the immune response following coadministration of Arexvy and Shingrix.

The rates of respiratory syncytial virus-associated hospitalizations were three to nine times higher for assisted living residents compared with the rates for community-dwelling older adults in a ...

Oregon public health officials are asking Oregonians to take steps to protect themselves and others from the slew of ...

The Upper Missouri District Health Unit (UMDHU) is urging people to get immunizations against respiratory infections.

GSK (GSK) reached the main goal in a Phase 3 trial for its RSV shot, Arexvy co--administered with Shingles vaccine Shingrix.

ADMA stock surges 76.2% in three months on strong performance and high growth prospects. It recently hit its 52-week high ...

British drugmaker GSK said on Wednesday administration of its respiratory syncytial virus (RSV) vaccine and shingles shot ...

RSV infects almost every child before they turn 2, and kills more than 100,000 infants worldwide each year. Machine learning ...